Article(id=1329914598104347606, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914534925545632, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.08.012, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1704643200000, receivedDateStr=2024-01-08, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005948806, onlineDateStr=2026-11-18, pubDate=1723219200000, pubDateStr=2024-08-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005948806, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005948806, creator=13701087609, updateTime=1795005948806, updator=13701087609, issue=Issue{id=1329914534925545632, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='8', pageStart='1045', pageEnd='1169', issueExtLink='null', onlineDate='null', pubDate='1723219200000', pubDateStr='2024-08-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005933743, creator='13701087609', updateTime=1795136196326, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330460896280818483, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914534925545632, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330460896280818484, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914534925545632, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1114, endPage=1120, ext={EN=ArticleExt(id=1329914598326645719, articleId=1329914598104347606, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Factors Affecting the Formation of Sulfamethoxazole-trimethoprim Co-crystal, columnId=1322624454216238014, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Paper, runingTitle=null, highlight=null, articleAbstract=

Drug co-crystal had a promising application in improving the solubility and dissolution of poorly water-soluble drugs. The compound sulfamethoxazole tablets contain two active pharmaceutical ingredients: sulfamethoxazole and trimethoprim, which may form co-crystal. In this paper, the existence of the co-crystal in the tablets had been confirmed by comparison with the standard samples. Then, three influence factors introduced in the formulation process, namely water content, pressure and temperature, on the formation of sulfamethoxazole-trimethoprim co-crystal was investigated. The results showed that water content was the key parameter for the formation of the co-crystal, whereas the co-crystal was formed only when the temperature reached above 128 ℃. Pressure was proved to have no effect on the formation of the co-crystal. The formed co-crystal had a stable crystal structure, which improved the compression resistance of the tablets.

, authors=Jihong LU1, Shanshan FAN1, Qiang WANG2, Xiangkui LIU2, Yuhui SHEN2, *, authorsList=Jihong LU, Shanshan FAN, Qiang WANG, Xiangkui LIU, Yuhui SHEN, authorCompany=null, correspAuthors=Yuhui SHEN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329914598578303960, articleId=1329914598104347606, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=影响磺胺甲𫫇唑-甲氧苄啶共晶形成的因素, columnId=1322624454384010176, journalTitle=中国医药工业杂志, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=

药物共晶在改善难溶性药物溶解和溶出方面有广阔的应用前景。复方磺胺甲𫫇唑片中含磺胺甲𫫇唑和甲氧苄啶,这2种活性药物成分可能形成共晶。经过与标准样品对比,确定该现象存在于片剂中。该文继续探讨了制剂工艺中水分含量、压力和温度这3个因素对磺胺甲𫫇唑-甲氧苄啶共晶形成的影响。结果显示,水分可诱导共晶形成;温度升高至128 ℃后才会形成共晶;压力对共晶的形成无影响。2种活性药物成分形成的共晶,晶体结构稳定,提高了片剂的抗压性。

, authors=陆纪宏1, 范珊珊1, 王强2, 刘相奎2, 沈裕辉2, *, authorsList=陆纪宏, 范珊珊, 王强, 刘相奎, 沈裕辉, authorCompany=null, correspAuthors=沈裕辉, authorNote=

陆纪宏(1975—),男,副主任药师,从事药品开发的研究。

, correspAuthorsNote=
沈裕辉(1981—),男,副研究员,从事药物合成及其固体状态的研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=wJKN9j66ooHzZTxVjBbG2w==, magXml=IEOTFCdkBctOW2DTqZ1Lug==, pdfUrl=null, pdf=67nz/wFanL9h5wQPbjQ3HA==, pdfFileSize=9854198, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=DmpWYaDOW3G/rR+jQZw6cw==, mapNumber=null, fund=null)}, authors=[Author(id=1329914598989345761, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914599064843235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914598989345761, language=EN, stringName=Jihong LU, firstName=Jihong, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Zhejiang Jinhua CONBA Bio-pharm. Co., Ltd., Jinhua 321016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914599136146404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914598989345761, language=CN, stringName=陆纪宏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.浙江金华康恩贝生物制药有限公司,浙江 金华 321016, bio={"content":"

陆纪宏(1975—),男,副主任药师,从事药品开发的研究。

"}, bioImg=null, bioContent=

陆纪宏(1975—),男,副主任药师,从事药品开发的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914598813184986, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, xref=1., ext=[AuthorCompanyExt(id=1329914598821573595, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598813184986, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Zhejiang Jinhua CONBA Bio-pharm. Co., Ltd., Jinhua 321016), AuthorCompanyExt(id=1329914598834156508, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598813184986, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.浙江金华康恩贝生物制药有限公司,浙江 金华 321016)])]), Author(id=1329914599220032486, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914599341667304, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599220032486, language=EN, stringName=Shanshan FAN, firstName=Shanshan, middleName=null, lastName=FAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Zhejiang Jinhua CONBA Bio-pharm. Co., Ltd., Jinhua 321016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914599412970473, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599220032486, language=CN, stringName=范珊珊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.浙江金华康恩贝生物制药有限公司,浙江 金华 321016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914598813184986, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, xref=1., ext=[AuthorCompanyExt(id=1329914598821573595, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598813184986, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Zhejiang Jinhua CONBA Bio-pharm. Co., Ltd., Jinhua 321016), AuthorCompanyExt(id=1329914598834156508, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598813184986, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.浙江金华康恩贝生物制药有限公司,浙江 金华 321016)])]), Author(id=1329914599484273643, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914599576548333, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599484273643, language=EN, stringName=Qiang WANG, firstName=Qiang, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914599643657198, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599484273643, language=CN, stringName=王强, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914598901265373, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, xref=2., ext=[AuthorCompanyExt(id=1329914598909653982, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329914598922236895, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203)])]), Author(id=1329914599706571760, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914599790457842, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599706571760, language=EN, stringName=Xiangkui LIU, firstName=Xiangkui, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914599861761011, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599706571760, language=CN, stringName=刘相奎, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914598901265373, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, xref=2., ext=[AuthorCompanyExt(id=1329914598909653982, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329914598922236895, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203)])]), Author(id=1329914599954035701, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=shenyuhui@126.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914600029533175, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599954035701, language=EN, stringName=Yuhui SHEN, firstName=Yuhui, middleName=null, lastName=SHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914600100836344, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599954035701, language=CN, stringName=沈裕辉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914598901265373, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, xref=2., ext=[AuthorCompanyExt(id=1329914598909653982, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329914598922236895, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203)])])], keywords=[Keyword(id=1329914600268608505, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, language=EN, orderNo=1, keyword=sulfamethoxazole), Keyword(id=1329914600348300282, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, language=EN, orderNo=2, keyword=trimethoprim), Keyword(id=1329914600415409147, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, language=EN, orderNo=3, keyword=co-crystal), Keyword(id=1329914600486712316, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, language=EN, orderNo=4, keyword=compound sulfamethoxazole tablet), Keyword(id=1329914600562209789, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, language=EN, orderNo=5, keyword=antibacterial drug), Keyword(id=1329914600620930046, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, language=CN, orderNo=1, keyword=磺胺甲𫫇唑), Keyword(id=1329914600700621823, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, language=CN, orderNo=2, keyword=甲氧苄啶), Keyword(id=1329914600780313600, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, language=CN, orderNo=3, keyword=共晶), Keyword(id=1329914600864198656, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, language=CN, orderNo=4, keyword=复方磺胺甲𫫇唑片), Keyword(id=1329914600935501825, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, language=CN, orderNo=5, keyword=抗菌药)], refs=[Reference(id=1329914601141022723, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=LOFTSSON T, BREWSTER M E.Pharmaceutical applications of cyclodextrins: basic science and product development [J].J Pharm Pharmacol, 2010, 62(11): 1607-1621., articleTitle=null, refAbstract=null), Reference(id=1329914601254268932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=吕扬,杜冠华.晶型药物[M].北京:人民卫生出版社,2009:28-32., articleTitle=null, refAbstract=null), Reference(id=1329914601325572101, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=ALMARSSON O, ZAWOROTKO M J.Crystal engineering of the composition of pharmaceutical phases.Do pharmaceutical co-crystals represent a new path to improved medicines? [J].Chem Commun, 2004, (17): 1889-1896., articleTitle=null, refAbstract=null), Reference(id=1329914601401069574, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=AITIPAMULA S, BANERJEE R, BANSAL A K, et al.Polymorphs, salts, and cocrystals: what’s in a name? [J].Cryst Growth Des, 2012, 12(5): 2147-2152., articleTitle=null, refAbstract=null), Reference(id=1329914601493344263, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=THIPPARABOINA R, KUMAR D, MITTAPALLI S, et al.Ionic, neutral, and hybrid acid-base crystalline adducts of lamotrigine with improved pharmaceutical performance [J].Cryst Growth Des, 2015, 15(12): 5816-5826., articleTitle=null, refAbstract=null), Reference(id=1329914601589813256, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=BANERJEE M, NIMKAR K, NAIK S, et al.Unlocking the potential of drug-drug cocrystals-a comprehensive review [J].J Control Release, 2022, 348: 456-469., articleTitle=null, refAbstract=null), Reference(id=1329914601682087945, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=MORADIYA H G, ISLAM M T, SCOUTARIS N, et al.Continuous manufacturing of high quality pharmaceutical cocrystals integrated with process analytical tools for in-line process control [J].Cryst Growth Des, 2016, 16(6): 3425-3434., articleTitle=null, refAbstract=null), Reference(id=1329914601761779722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=ENDE D A, ANDERSON S R, SALAN J S.Development and scale-up of cocrystals using resonant acoustic mixing [J].Org Process Res Dev, 2014, 18(2): 331-341., articleTitle=null, refAbstract=null), Reference(id=1329914601841471499, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=CUADRA I A, CABAÑAS A, CHEDA J A R, et al.Pharmaceutical co-crystals of the anti-inflammatory drug diflunisal and nicotinamide obtained using supercritical CO2 as an antisolvent [J].J CO2 Util, 2016, 13: 29-37., articleTitle=null, refAbstract=null), Reference(id=1329914601912774668, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=KALE D P, ZODE S S, BANSAL A K.Challenges in translational development of pharmaceutical cocrystals [J].J Pharm Sci, 2017, 106(2): 457-470., articleTitle=null, refAbstract=null), Reference(id=1329914601992466445, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=GU J, NOE A, CHANDRA P, et al.Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor(ARNi) [J].J Clin Pharmacol, 2010, 50(4): 401-414., articleTitle=null, refAbstract=null), Reference(id=1329914602072158222, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=DESAI A S, MCMURRAY J J, PACKER M, et al.Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients [J].Eur Heart J, 2015, 36(30): 1990-1997., articleTitle=null, refAbstract=null), Reference(id=1329914602147655695, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ALMANSA C, MERCÈ R, TESSON N, et al.Co-crystal of tramadol hydrochloride-celecoxib(ctc): a novel API-API co-crystal for the treatment of pain [J].Cryst Growth Des, 2017, 17(4): 1884-1892., articleTitle=null, refAbstract=null), Reference(id=1329914602218958864, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=VIDELA S, LAHJOU M, VAQUÉ A, et al.Single-dose pharmacokinetics of co-crystal of tramadol-celecoxib: results of a four-way randomized open-label phase I clinical trial in healthy subjects [J].Br J Clin Pharmacol, 2017, 83(12): 2718-2728., articleTitle=null, refAbstract=null), Reference(id=1329914602302844945, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=GIORDANO F, BETTINETTI G P, MANNA A L, et al.Preparation and characterization of the sulfamethoxazole-trimethoprim 1∶1 molecular compound [J].Farmaco Sci, 1977, 32(12): 889-896., articleTitle=null, refAbstract=null), Reference(id=1329914602369953810, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=ZAINI E, SUMIRTAPURA Y C, SOEWANDHI, et al.Cocrystalline phase transformation of binary mixture of trimethoprim and sulfamethoxazole by slurry technique [J].Asian J Pharm Clin Res, 2010, 3(4): 26-29., articleTitle=null, refAbstract=null), Reference(id=1329914602441256979, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=ERIZAL Z, SUMIRTAPURA Y C, HALIM A, et al.Formation and characterization of sulfamethoxazole-trimethoprim cocrystal by milling process [J].J Appl Pharm Sci, 2017, 7(12): 169-173., articleTitle=null, refAbstract=null), Reference(id=1329914602546114580, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG S S, GUILLORY J K.Polymorphism in sulfonamides [J].J Pharm Sci, 1972, 61(1): 26-40., articleTitle=null, refAbstract=null), Reference(id=1329914602613223445, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=KAWASHIMA Y, LIN S Y, TAKENAKA H.Polymorphism and drug release behavior of spray-dried microcapsules of sulfamethoxazole with polysaccharide gum and colloidal silica[J].Drug Dev Ind Pharm, 1983, 9(8): 1445-1463., articleTitle=null, refAbstract=null), Reference(id=1329914602680332310, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=BETTINETTI G P, GIORDANO F, MANNA A L, et al. Trimethoprim crystal forms [J].J Pharm Pharmacol, 1976, 28(1): 87-88., articleTitle=null, refAbstract=null), Reference(id=1329914602751635479, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=BETTINETTI G P, GIORDANO F, MANNA A L.Polymorphism of trimethoprim Ⅰ.Preparation of polymorph modifications(Ⅰ, Ⅱ, Ⅲ) and of a hydrate (TMP·H2O) [J].Boll Chim Farm, 1978, 117(9): 522-529., articleTitle=null, refAbstract=null), Reference(id=1329914602831327256, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=MADDILETI D, SWAPNA B, NANGIA A.Tetramorphs of the antibiotic drug trimethoprim: characterization and stability[J].Cryst Growth Des, 2015, 15(4): 1745-1756., articleTitle=null, refAbstract=null), Reference(id=1329914602902630425, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=SUI J J, LUO Y, ZHAI J H, et al.Solubility measurement, model evaluation and molecular simulations of aprepitant(form Ⅰ) in eight pure solvents [J].J Mol Liq, 2020, 304: 112723., articleTitle=null, refAbstract=null), Reference(id=1329914602986516506, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=LOU B, XU Y, QIN X L, et al.Solubility measurement and molecular simulation of unsolvated and solvated estrogen receptor agonist (R)-equol in binary solvents (alcohols+n-heptane) from 273.15 K to 333.15 K [J].J Mol Liq, 2023, 376: 121460., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329914601044553730, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, awardId=23DZ2292600, language=CN, fundingSource=上海市2023年度“科技创新行动计划”专业技术服务平台项目(23DZ2292600), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329914598813184986, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, xref=1., ext=[AuthorCompanyExt(id=1329914598821573595, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598813184986, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Zhejiang Jinhua CONBA Bio-pharm. Co., Ltd., Jinhua 321016), AuthorCompanyExt(id=1329914598834156508, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598813184986, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.浙江金华康恩贝生物制药有限公司,浙江 金华 321016)]), AuthorCompany(id=1329914598901265373, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, xref=2., ext=[AuthorCompanyExt(id=1329914598909653982, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329914598922236895, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.08.012, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.08.012, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.08.012, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.08.012, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1723219200000, fullTextJson=null, articleText=null, reference=null)
收藏切换
影响磺胺甲𫫇唑-甲氧苄啶共晶形成的因素
陆纪宏 1 , 范珊珊 1 , 王强 2 , 刘相奎 2 , 沈裕辉 2, *
中国医药工业杂志 | 研究论文 2024,55(8): 1114-1120
收起
收藏切换
中国医药工业杂志 |研究论文 2024 , 55 (8) : 1114 -1120
影响磺胺甲𫫇唑-甲氧苄啶共晶形成的因素
全屏
[Author(id=1329914598989345761, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914599064843235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914598989345761, language=EN, stringName=Jihong LU, firstName=Jihong, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Zhejiang Jinhua CONBA Bio-pharm. Co., Ltd., Jinhua 321016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914599136146404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914598989345761, language=CN, stringName=陆纪宏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.浙江金华康恩贝生物制药有限公司,浙江 金华 321016, bio={"content":"

陆纪宏(1975—),男,副主任药师,从事药品开发的研究。

"}, bioImg=null, bioContent=

陆纪宏(1975—),男,副主任药师,从事药品开发的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914598813184986, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, xref=1., ext=[AuthorCompanyExt(id=1329914598821573595, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598813184986, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Zhejiang Jinhua CONBA Bio-pharm. Co., Ltd., Jinhua 321016), AuthorCompanyExt(id=1329914598834156508, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598813184986, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.浙江金华康恩贝生物制药有限公司,浙江 金华 321016)])]), Author(id=1329914599220032486, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914599341667304, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599220032486, language=EN, stringName=Shanshan FAN, firstName=Shanshan, middleName=null, lastName=FAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Zhejiang Jinhua CONBA Bio-pharm. Co., Ltd., Jinhua 321016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914599412970473, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599220032486, language=CN, stringName=范珊珊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.浙江金华康恩贝生物制药有限公司,浙江 金华 321016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914598813184986, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, xref=1., ext=[AuthorCompanyExt(id=1329914598821573595, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598813184986, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Zhejiang Jinhua CONBA Bio-pharm. Co., Ltd., Jinhua 321016), AuthorCompanyExt(id=1329914598834156508, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598813184986, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.浙江金华康恩贝生物制药有限公司,浙江 金华 321016)])]), Author(id=1329914599484273643, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914599576548333, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599484273643, language=EN, stringName=Qiang WANG, firstName=Qiang, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914599643657198, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599484273643, language=CN, stringName=王强, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914598901265373, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, xref=2., ext=[AuthorCompanyExt(id=1329914598909653982, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329914598922236895, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203)])]), Author(id=1329914599706571760, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914599790457842, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599706571760, language=EN, stringName=Xiangkui LIU, firstName=Xiangkui, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914599861761011, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599706571760, language=CN, stringName=刘相奎, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914598901265373, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, xref=2., ext=[AuthorCompanyExt(id=1329914598909653982, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329914598922236895, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203)])]), Author(id=1329914599954035701, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=shenyuhui@126.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914600029533175, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599954035701, language=EN, stringName=Yuhui SHEN, firstName=Yuhui, middleName=null, lastName=SHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914600100836344, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, authorId=1329914599954035701, language=CN, stringName=沈裕辉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914598901265373, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, xref=2., ext=[AuthorCompanyExt(id=1329914598909653982, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329914598922236895, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914598104347606, companyId=1329914598901265373, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203)])])]
陆纪宏1, 范珊珊1, 王强2, 刘相奎2, 沈裕辉2, *
作者信息
  • 1.浙江金华康恩贝生物制药有限公司,浙江 金华 321016
  • 2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203
通讯作者:
沈裕辉(1981—),男,副研究员,从事药物合成及其固体状态的研究。E-mail:
作者简介:

陆纪宏(1975—),男,副主任药师,从事药品开发的研究。

Factors Affecting the Formation of Sulfamethoxazole-trimethoprim Co-crystal
Jihong LU1, Shanshan FAN1, Qiang WANG2, Xiangkui LIU2, Yuhui SHEN2, *
Affiliations
  • 1.Zhejiang Jinhua CONBA Bio-pharm. Co., Ltd., Jinhua 321016
  • 2.Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203
出版时间: 2024-08-10 doi: 10.16522/j.cnki.cjph.2024.08.012
文章导航
收藏切换

药物共晶在改善难溶性药物溶解和溶出方面有广阔的应用前景。复方磺胺甲𫫇唑片中含磺胺甲𫫇唑和甲氧苄啶,这2种活性药物成分可能形成共晶。经过与标准样品对比,确定该现象存在于片剂中。该文继续探讨了制剂工艺中水分含量、压力和温度这3个因素对磺胺甲𫫇唑-甲氧苄啶共晶形成的影响。结果显示,水分可诱导共晶形成;温度升高至128 ℃后才会形成共晶;压力对共晶的形成无影响。2种活性药物成分形成的共晶,晶体结构稳定,提高了片剂的抗压性。

磺胺甲𫫇唑  /  甲氧苄啶  /  共晶  /  复方磺胺甲𫫇唑片  /  抗菌药

Drug co-crystal had a promising application in improving the solubility and dissolution of poorly water-soluble drugs. The compound sulfamethoxazole tablets contain two active pharmaceutical ingredients: sulfamethoxazole and trimethoprim, which may form co-crystal. In this paper, the existence of the co-crystal in the tablets had been confirmed by comparison with the standard samples. Then, three influence factors introduced in the formulation process, namely water content, pressure and temperature, on the formation of sulfamethoxazole-trimethoprim co-crystal was investigated. The results showed that water content was the key parameter for the formation of the co-crystal, whereas the co-crystal was formed only when the temperature reached above 128 ℃. Pressure was proved to have no effect on the formation of the co-crystal. The formed co-crystal had a stable crystal structure, which improved the compression resistance of the tablets.

sulfamethoxazole  /  trimethoprim  /  co-crystal  /  compound sulfamethoxazole tablet  /  antibacterial drug
陆纪宏, 范珊珊, 王强, 刘相奎, 沈裕辉. 影响磺胺甲𫫇唑-甲氧苄啶共晶形成的因素. 中国医药工业杂志, 2024 , 55 (8) : 1114 -1120 . DOI: 10.16522/j.cnki.cjph.2024.08.012
Jihong LU, Shanshan FAN, Qiang WANG, Xiangkui LIU, Yuhui SHEN. Factors Affecting the Formation of Sulfamethoxazole-trimethoprim Co-crystal[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (8) : 1114 -1120 . DOI: 10.16522/j.cnki.cjph.2024.08.012
  • 上海市2023年度“科技创新行动计划”专业技术服务平台项目(23DZ2292600)
参考文献 引证文献
排序方式:
[1]
LOFTSSON T, BREWSTER M E.Pharmaceutical applications of cyclodextrins: basic science and product development [J].J Pharm Pharmacol, 2010, 62(11): 1607-1621.
[2]
吕扬,杜冠华.晶型药物[M].北京:人民卫生出版社,2009:28-32.
[3]
ALMARSSON O, ZAWOROTKO M J.Crystal engineering of the composition of pharmaceutical phases.Do pharmaceutical co-crystals represent a new path to improved medicines? [J].Chem Commun, 2004, (17): 1889-1896.
[4]
AITIPAMULA S, BANERJEE R, BANSAL A K, et al.Polymorphs, salts, and cocrystals: what’s in a name? [J].Cryst Growth Des, 2012, 12(5): 2147-2152.
[5]
THIPPARABOINA R, KUMAR D, MITTAPALLI S, et al.Ionic, neutral, and hybrid acid-base crystalline adducts of lamotrigine with improved pharmaceutical performance [J].Cryst Growth Des, 2015, 15(12): 5816-5826.
[6]
BANERJEE M, NIMKAR K, NAIK S, et al.Unlocking the potential of drug-drug cocrystals-a comprehensive review [J].J Control Release, 2022, 348: 456-469.
[7]
MORADIYA H G, ISLAM M T, SCOUTARIS N, et al.Continuous manufacturing of high quality pharmaceutical cocrystals integrated with process analytical tools for in-line process control [J].Cryst Growth Des, 2016, 16(6): 3425-3434.
[8]
ENDE D A, ANDERSON S R, SALAN J S.Development and scale-up of cocrystals using resonant acoustic mixing [J].Org Process Res Dev, 2014, 18(2): 331-341.
[9]
CUADRA I A, CABAÑAS A, CHEDA J A R, et al.Pharmaceutical co-crystals of the anti-inflammatory drug diflunisal and nicotinamide obtained using supercritical CO2 as an antisolvent [J].J CO2 Util, 2016, 13: 29-37.
[10]
KALE D P, ZODE S S, BANSAL A K.Challenges in translational development of pharmaceutical cocrystals [J].J Pharm Sci, 2017, 106(2): 457-470.
[11]
GU J, NOE A, CHANDRA P, et al.Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor(ARNi) [J].J Clin Pharmacol, 2010, 50(4): 401-414.
[12]
DESAI A S, MCMURRAY J J, PACKER M, et al.Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients [J].Eur Heart J, 2015, 36(30): 1990-1997.
[13]
ALMANSA C, MERCÈ R, TESSON N, et al.Co-crystal of tramadol hydrochloride-celecoxib(ctc): a novel API-API co-crystal for the treatment of pain [J].Cryst Growth Des, 2017, 17(4): 1884-1892.
[14]
VIDELA S, LAHJOU M, VAQUÉ A, et al.Single-dose pharmacokinetics of co-crystal of tramadol-celecoxib: results of a four-way randomized open-label phase I clinical trial in healthy subjects [J].Br J Clin Pharmacol, 2017, 83(12): 2718-2728.
[15]
GIORDANO F, BETTINETTI G P, MANNA A L, et al.Preparation and characterization of the sulfamethoxazole-trimethoprim 1∶1 molecular compound [J].Farmaco Sci, 1977, 32(12): 889-896.
[16]
ZAINI E, SUMIRTAPURA Y C, SOEWANDHI, et al.Cocrystalline phase transformation of binary mixture of trimethoprim and sulfamethoxazole by slurry technique [J].Asian J Pharm Clin Res, 2010, 3(4): 26-29.
[17]
ERIZAL Z, SUMIRTAPURA Y C, HALIM A, et al.Formation and characterization of sulfamethoxazole-trimethoprim cocrystal by milling process [J].J Appl Pharm Sci, 2017, 7(12): 169-173.
[18]
YANG S S, GUILLORY J K.Polymorphism in sulfonamides [J].J Pharm Sci, 1972, 61(1): 26-40.
[19]
KAWASHIMA Y, LIN S Y, TAKENAKA H.Polymorphism and drug release behavior of spray-dried microcapsules of sulfamethoxazole with polysaccharide gum and colloidal silica[J].Drug Dev Ind Pharm, 1983, 9(8): 1445-1463.
[20]
BETTINETTI G P, GIORDANO F, MANNA A L, et al. Trimethoprim crystal forms [J].J Pharm Pharmacol, 1976, 28(1): 87-88.
[21]
BETTINETTI G P, GIORDANO F, MANNA A L.Polymorphism of trimethoprim Ⅰ.Preparation of polymorph modifications(Ⅰ, Ⅱ, Ⅲ) and of a hydrate (TMP·H2O) [J].Boll Chim Farm, 1978, 117(9): 522-529.
[22]
MADDILETI D, SWAPNA B, NANGIA A.Tetramorphs of the antibiotic drug trimethoprim: characterization and stability[J].Cryst Growth Des, 2015, 15(4): 1745-1756.
[23]
SUI J J, LUO Y, ZHAI J H, et al.Solubility measurement, model evaluation and molecular simulations of aprepitant(form Ⅰ) in eight pure solvents [J].J Mol Liq, 2020, 304: 112723.
[24]
LOU B, XU Y, QIN X L, et al.Solubility measurement and molecular simulation of unsolvated and solvated estrogen receptor agonist (R)-equol in binary solvents (alcohols+n-heptane) from 273.15 K to 333.15 K [J].J Mol Liq, 2023, 376: 121460.
2024年第55卷第8期
24
6
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.08.012
  • 接收时间:2024-01-08
  • 首发时间:2026-11-18
  • 出版时间:2024-08-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-01-08
基金
上海市2023年度“科技创新行动计划”专业技术服务平台项目(23DZ2292600)
作者信息
    1.浙江金华康恩贝生物制药有限公司,浙江 金华 321016
    2.中国医药工业研究总院上海医药工业研究院有限公司,上海 201203

通讯作者:

沈裕辉(1981—),男,副研究员,从事药物合成及其固体状态的研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.08.012
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏